GlassScriptPhysician profile
Nancy S Rose
NPI 1083876882
$1,846.85
in general payments reported to CMS, 2019-2025
14 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Adult Health (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $186).
See the full distribution for Adult Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $352 · 2022: $439 · 2023: $333 · 2024: $390 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,056.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $914.33 | 2021-2025 | Repatha, Repatha |
| Abbott Laboratories | $285.43 | 2022-2024 | Ultreon, Cardiomems |
| Boston Scientific Corporation | $153.44 | 2022-2025 | Watchman Flx, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $121.75 | 2021-2025 | |
| Abiomed | $78.28 | 2023-2024 | Impella |
| Edwards Lifesciences Corporation | $64.91 | 2021 | |
| Impulse Dynamics (USA) INC. | $55.29 | 2023 | Optimizer |
| Kiniksa Pharmaceuticals, LTD. | $39.07 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $36.10 | 2022-2023 | Xarelto |
| Becton, Dickinson and Company | $23.08 | 2024 | Venovo |
| Novo Nordisk INC | $22.19 | 2025 | Ozempic |
| Atricure, INC. | $19.85 | 2023 | |
| Esperion Therapeutics, INC. | $18.81 | 2021 | |
| Ge Healthcare | $14.32 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.